Phase IIB Randomized, Placebo Controlled Trial of Pioglitazone for Oral Premalignant Lesions An Inter-Consortium Collaborative Study.

Trial Profile

Phase IIB Randomized, Placebo Controlled Trial of Pioglitazone for Oral Premalignant Lesions An Inter-Consortium Collaborative Study.

Discontinued
Phase of Trial: Phase II

Latest Information Update: 12 Apr 2016

At a glance

  • Drugs Pioglitazone (Primary)
  • Indications Orofacial cancer
  • Focus Therapeutic Use
  • Most Recent Events

    • 29 Mar 2016 Primary endpoint has been amended as per ClinicalTrials.gov.
    • 29 Mar 2016 According to ClinicalTrials.gov Status changed from completed to discontinued due to slow accrual.
    • 04 Sep 2013 Additional lead trial center added as reported by European Clinical Trials Database.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top